| 宋晓萍1△ 董全江1 李程2 孙明娥1 路建中1 孙滨1.鲍曼不动杆菌耐药性监测与碳青霉烯酶基因型研究[J].,2011,11(7):1336-1339 |
| 鲍曼不动杆菌耐药性监测与碳青霉烯酶基因型研究 |
| Acinetobacter baumannii resistance monitoring and research ofcarbapenemase genotypes |
| |
| DOI： |
| 中文关键词: 鲍曼不动杆菌 碳青霉烯酶 基因型 |
| 英文关键词: Acinetobacter baumannii Carbapenemases genetype |
| 基金项目: |
|
| 摘要点击次数: 696 |
| 全文下载次数: 958 |
| 中文摘要: |
| 目的：对鲍曼不动杆菌耐药性及碳青霉烯酶基因型进行研究，以指导临床合理应用抗生素。方法：收集青岛市海慈医疗集团
2009 年6 月至2010 年6 月从临床分离的鲍曼不动杆菌60 株,用琼脂稀释法测定最低抑菌浓度(M IC) ,改良Hodge 试验检测碳青
霉烯酶，用PCR 法检测OXA-23，OXA-24，OXA-58 基因，并对PCR 产物进行测序。结果：①鲍曼不动杆菌检出率前两位是ICU 病
房和呼吸科病房，分别占32.3％和27.4％，多重耐药鲍曼不杆菌阳性率最高的是ICU，为70.6％（12/17），其次为呼吸科病房，为
35.0％（7／20），哌拉西林、哌拉西林/ 他唑巴坦、头孢曲松、头孢他啶、头孢吡肟、亚胺培南、美罗培南、庆大霉索、阿米卡星、环丙
沙星、左氧氟沙星、加替沙星、头孢哌酮/ 舒巴坦、氨曲南耐药率分别为92.3%、55.4%、88.6% 、86.3%、80.3 %、30.0%、35.0%、
76.6%、79.6 %、75.1%、87.1%、48.3%、42.0 %和79.6%.②在21 株耐碳青霉烯类鲍曼不动杆菌，有14 株碳青霉烯酶表型阳性，检
出率为66.7%，有18 株PCR 扩增出OXA-23 基因，检出率85.7％，全部菌株blaOXA-24 及blaOXA-58PCR 扩增均为阴性, PCR
产物测序表明与鲍曼不动杆菌（AY795964.1）blaOXA-23 基因序列100％同源。结论：鲍曼不动杆菌多重耐药性严重；表型和基因
型检测证实本院临床分离鲍曼不动杆菌对碳青霉烯类耐药机制主要是产OXA-23 型酶。 |
| 英文摘要: |
| Objective: To investigate antibiotic resistance and carbapenemases genotype in A cinetobacter baumannii, so as to
guide the rational use of antibiotics in clinical. Methods: A total of 60 clinical isolates were collected from June 2009 to June 2010 in the
Qingdao Hiser Medical Group .Agar dilution method was used to test minimum inhibitory concentrations(MICs)of 14 antibiotics, Hodge
test was used to detect carbapenemases, PCR was used to detect OXA-23，OXA-24，OXA-58 genes ,and the positive products of OXA
genes were sequenced. Results: ①The first and the second detection rate of A.baumannii is ICU ward and respiratory ward, which accounted
for 32.3% and 27.4%, the highest positive rate of Multi-drug resistant A.baumannii is ICU, 70.6% (12/17), followed by respiratory
ward, 35.0% (7 / 20). the resistance rates of 60 isolates to piperacillin, piperacillin / tazobactam, ceftriaxone, ceftazidime, cefepime,
imipenem, meropenem, Gentamicin , amikacin, ciprofloxacin, levofloxacin, gatifloxacin cefoperazone / sulbactam and aztreonam, were
92.3%, 55.4%, 88.6%, 86.3%, 80.3%, 30.0%, 35.0%, 76.6%, 79.6%, 75.1%, 87.1% 48.3%, 42.0% and 79.6% respectively. ②In the 21
strains of carbapenem-resistant Acinetobacter baumannii，carbapenemase phenotypic testing results showed that the posive strains were
14，the detection rate of which was 66.7%.18 strains detected OXA-23 gene, the detection rate of which was 85.7％. All strains were not
detected blaOXA-24 and blaOXA-58 genes. The sequenced results were absolutely homology with blaOXA-23 gene. Conclusion: The
multi-drug resistance phenomenon of Ab are serious; Phenotype and genotype test confirmed the mainly mechanism of carbapenem-resistant
Acinetobacter baumannii are producing OXA-23-type enzyme in our hospital. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
